Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

Eye care giant Alcon appears to have gained the upper hand in the ongoing power struggle with Aurion Biotech by securing a ...

Rating for Alcon jumped into a new percentile Tuesday, as it got a lift from 70 to 73. Please watch the video at ...

This compares to the stock's 2.1% loss over the past four weeks. Alcon scored a strong price increase driven by the optimism surrounding the company’s aggressive move on the M&A front.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Stifel Nicolaus analyst Thomas Stephan maintained a Buy rating on Alcon (ALC – Research Report) today and set a price target of $100.00. The ...

In a welcome move, Alcon saw its Relative Strength Rating rise from 68 to 71 on Tuesday. Please watch the video at Investors.com - How To Buy Stocks: Do You Know Your Stock's Personality Type? IBD's ...

Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolio Next generation technology ...

With the company strategically growing through innovation and market expansion, we expect the stock to continue its upward movement in the coming days. Alcon is experiencing inflationary pressures ...